Alpine Immune Sciences Announces Participation in Fireside Chat at the 5th Annual Evercore ISI HealthCONx Conference
23 November 2022 - 8:15AM
Business Wire
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading
clinical-stage immunotherapy company focused on developing
innovative treatments for autoimmune and inflammatory diseases,
today announced the Company will participate in a fireside chat at
the 5th Annual Evercore ISI HealthCONx Conference on Wednesday,
November 30, 2022, at 12:35 p.m. ET/9:35 a.m. PT.
A live webcast of the fireside chat will be available in the
investor relations section of the Company’s website at
https://ir.alpineimmunesciences.com/events and a replay will be
available on the Company's website for 90 days following the live
event.
About Alpine Immune Sciences
Alpine Immune Sciences is committed to leading a new wave of
immune therapeutics. With world-class research and development
capabilities, a highly productive scientific platform, and a proven
management team, Alpine is seeking to create first- or
best-in-class multifunctional immunotherapies via unique protein
engineering technologies to improve patients’ lives. Alpine has
entered into strategic collaborations with leading global
biopharmaceutical companies and has a diverse pipeline of clinical
and preclinical candidates in development. For more information,
visit www.alpineimmunesciences.com.
Follow @AlpineImmuneSci on Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221122005816/en/
Temre Johnson (Investors) Alpine Immune Sciences, Inc.
ir@alpineimmunesciences.com
Kelli Perkins (Media) Red House kelli@redhousecomms.com
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Apr 2023 to Apr 2024